Exceptional OutcomesRanger demonstrated consistent results with nearly 90% patency at 12-months in the RANGER II SFA and COMPARE Randomized Controlled Trials. |
|
Effortless DeliverabilityBuilt on the market-leading .018” Sterling balloon platform with .014”/.018" guidewire compatibility, Ranger has the lowest tip entry profile. |
|
Efficient Drug TransferRanger is a low dose DCB with a uniquely formulated TransPax coating that results in highly efficient drug transfer. This enables extremely targeted drug delivery, achieving nearly 90% primary patency, with the least amount of downstream particulates and low systemic drug exposure to the patient. |
Product Code | - |
Application | Paclitaxel-Coated PTA Balloon Catheter |
Manufacturer Country | USA |
Guarantee Type | Based on company recommendations |